Les analogues du GLP-1 et les doubles analogues GIP/GLP-1 : risques associés au mésusage et à l’utilisation hors indication pour la perte de poids
Safety Classified by Officially
The FAMHP has been alerted to cases of misuse and off-label use of GLP-1 analogues and GIP/GLP-1 dual analogues, particularly for the purpose of weight loss. Here are a few reminders about the proper use of these medicines. …
This is an extract. The publication continues at the source.
Read the original at the source: https://www.famhp.be/fr/news/les_analogues_du_glp_1_et_les_doubles_analogues_gipglp_1_risques_associes_au_mesusage_et_a
Officially imported this from Federal Agency for Medicines and Health Products (FAMHP)’s own source and shows an extract. If you work there, claiming the profile and verifying the domain lets you choose to show the full text here.
Provenance
- Organization
- Federal Agency for Medicines and Health Products (FAMHP) — imported from official source
- Official source
- https://www.famhp.be/en/rss.xml RSS
- Imported
- October 20, 2026 10:32
- Versions
- 1 recorded
- Identity
-
110426 at https://www.famhp.be